Read by QxMD icon Read


Covadonga Alvarez-Lopez, Javier De Santiago, Antonio Piñera, Roberto Rodriguez, Beatriz Herrero, Maria Herrera, Jaime Pillado, Ignacio Zapardiel
BACKGROUND: To determine the utility of three-dimensional (3D) sonography to control the position of hysteroscopic sterilizing device compared to hysterosalpingography (HSG). METHODS: A prospective observational study was carried out on 139 patients who underwent hysteroscopic tubal occlusion method between February 2012 and May 2013. Patients underwent 3D ultrasound scan to control device positioning, and they also underwent HSG as an additional control method...
October 6, 2016: Gynecologic and Obstetric Investigation
C M Santiago, N Astill
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
A Nargund, R Penketh, C Thomas, L Groves, S Hill
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
M Berkkanoglu, K Coetzee, H Bulut, K Ozgur
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
M S Mahmoud
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
S Herve, P Panayotopoulos, P Descamps, G Legendre
No abstract text is available yet for this article.
September 2016: Ultrasound in Obstetrics & Gynecology
Sara Siemons, Michel Vleugels, Hugo van Eijndhoven
STUDY OBJECTIVE: To evaluate whether de novo development of nickel sensitization is related to placement of the Essure device, and to evaluate whether the grade of reaction to nickel increased after device placement in patients with a confirmed nickel allergy. DESIGN: Prospective cohort study (Canadian Task Force classification II-2). SETTING: Two nonacademic training hospitals in The Netherlands. PATIENTS: Healthy women of childbearing age desiring permanent sterilization...
September 13, 2016: Journal of Minimally Invasive Gynecology
Huse Kamencic, Luke Thiel, Erwin Karreman, John Thiel
STUDY OBJECTIVES: To examine the surgical indications and pathologic findings in patients undergoing a second surgery following placement of the Essure permanent birth control system to determine the role of Essure in developing new onset pelvic pain. DESIGN: Retrospective cohort (Canadian Task Force classification II-2). SETTING: Tertiary level hospital. PATIENTS: Women who have had Essure placement and subsequent second surgery...
August 25, 2016: Journal of Minimally Invasive Gynecology
Melody Y Hou
Hysteroscopic sterilisation with Essure requires confirmation of tubal occlusion by hysterosalpingogram or microinsert position by transvaginal sonography 3 months after placement before women can rely on the method for pregnancy prevention. A 39-year-old woman underwent hysteroscopic sterilisation via Essure, with successful bilateral tubal occlusion documented on hysterosalpingogram. She had a subsequent unintended pregnancy and termination, and presented with persistent pelvic pain and other non-specific symptoms...
2016: BMJ Case Reports
Daniella De Batista Depes, Ana Maria Gomes Pereira, Umberto Gazi Lippi, João Alfredo Martins, Reginaldo Guedes Coelho Lopes
OBJECTIVE: To evaluate results of early tubal occlusions performed by hysteroscopy (Essure®). METHODS: This prospective study included 38 patients, 73.7% of them were white, mean age 34.5 years, they have had on average 3 pregnancies and 2.7 of deliveries. A total of 86.8% of patients previously prepared the endometrium. All procedures were carried out at outpatient unit without anesthesia. RESULTS: Insertion rate of the device was 100% at a mean time of 4 minutes and 50 seconds...
April 2016: Einstein
E Scott Sills, Gianpiero D Palermo
We describe the successful removal of a pelvic contraceptive coil in a symptomatic 46-year-old patient who had Essure devices for four years, using a combined hysteroscopy-laparoscopy-fluoroscopy approach. Following normal hysteroscopy, at laparoscopy the right Essure implant was disrupted and its outer nitinol coil had perforated the fallopian tube. However, the inner rod (containing polyethylene terephthalate) had migrated to an extrapelvic location, near the proximal colon. In contrast, the left implant was situated within the corresponding tube...
July 2016: Obstetrics & Gynecology Science
Luke Thiel, Darrien Rattray, John Thiel
STUDY OBJECTIVE: Present a laparoscopic technique for complete removal of Essure™ microinserts (including nitinol coil and PET fibers). DESIGN: Step-wise instruction using video. The study was granted a Research Ethics Board exemption as the Regina Qu'Appelle Health Region Research Ethics Board does not ethics board approval for single case submissions. SETTING: Recent concern regarding adverse outcomes (persistent pelvic pain, device malposition, nickel allergy) following Essure™ placement has led to a small percentage of women requesting removal of the coils(1)...
July 12, 2016: Journal of Minimally Invasive Gynecology
Sabriya Rice
No abstract text is available yet for this article.
March 7, 2016: Modern Healthcare
M Simorre, P Lopes, C Le Vaillant
OBJECTIVE: The aim of this study is to propose an analysis of the route and the curvature of the Essure(®) system in 3D ultrasound to determine their correct location so as not to miss a tubal perforation. METHODS: This is a retrospective single center study during 2 years analyzing 92 3D ultrasound performed by a single sonographer. Implant placement was performed by different operators. One prescribed 3D ultrasound control in case of difficulties with the installation; other indications where systematics...
June 16, 2016: Gynécologie, Obstétrique & Fertilité
Darrien Rattray, Peter Thiel, Ian Suchet, John Thiel
STUDY OBJECTIVES: To examine the imaging modality used in cases of Essure failures and determine the cause of the unintended pregnancies (noncompliance to follow-up recommendations, misinterpretation of the imaging test, or device failure). DESIGN: Retrospective, single-center interventional cohort (Canadian Task Force classification II-2). SETTING: Tertiary level hospital. PATIENTS: Women who have had Essure placement and subsequent pregnancy...
September 2016: Journal of Minimally Invasive Gynecology
Shlomo B Cohen, Jerome Bouaziz, Eyal Schiff, Alexander Simon, Michel Nadjary, Mordechai Goldenberg, Raoul Orvieto, Ariel Revel
STUDY OBJECTIVE: To investigate whether hysteroscopic proximal tubal occlusion with Essure microinserts (Conceptus Inc.; Bayer, AG, North Rhine-Westphalia, Germany) can improve pregnancy rates in patients with hydrosalpinges who had failed in vitro fertilization (IVF) treatment. DESIGN: A prospective cohort study. SETTING: University-affiliated tertiary centers. PATIENTS: Twenty-four consecutive women with hydrosalpinges who had failed IVF treatment were included...
September 2016: Journal of Minimally Invasive Gynecology
Marina W Barbosa, Alexandros Sotiriadis, Stefania I Papatheodorou, Velja Mijatovic, Carolina O Nastri, Wellington P Martins
OBJECTIVES: Essure has been tested as an alternative treatment for women with hydrosalpinx before embryo transfer (ET). However, the persistence of a foreign body inside the uterine cavity might have a negative impact on pregnancy outcomes. The present systematic review aimed to identify, appraise and summarize the available evidence regarding the effectiveness and safety of using Essure for women with hydrosalpinx prior to embryo transfer. METHODS: We searched for studies in PubMed, Scopus, CENTRAL, Web of Science and ClinicalTrials...
May 6, 2016: Ultrasound in Obstetrics & Gynecology
James Casey, Francisco Aguirre, Amanda Yunker
The following presents a case series of 29 referral patients who underwent laparoscopic Essure removal for the indication of suspected Essure-related pelvic pain and to describe patient characteristics, intraoperative findings and postoperative pain outcomes. Laparoscopic removal for Essure-associated pelvic pain is a safe and effective treatment.
August 2016: Contraception
E Scott Sills, Marie M Dalton
OBJECTIVE: We present clinical data on two patients who underwent hysteroscopic sterilization (HS) 11 years apart using the Essure® (Bayer Inc., Whippany, NJ) device. MATERIALS AND METHODS: Symptoms and resolution are described for symptomatic Essure® patients. RESULTS: Case 1 (G3P1) underwent HS in 2004 at age 21. Performed in a physician's office without anesthesia, HS involved placement of >2 Essure® devices which was followed by severe, unrelenting pelvic pain...
April 2016: Surgical Technology International
Wendaline M VanBuren, Ian B Suchet, John A Thiel, Erwin Karreman
OBJECTIVE: We hypothesize that the shape of the Essure microinsert on ultrasound is able to predict complications evident on hysterosalpingogram (HSG), the accepted gold standard. METHOD AND MATERIALS: From July 2, 2009 to July 2, 2012, 441 women at our institution received Essure microinsert placement for the purpose of permanent sterilization. 2D and 3D coronal plane transvaginal ultrasounds were performed three months after Essure microinsert placement. Those patients with complications identified on ultrasound, a non-diagnostic ultrasound, or following a difficult insertion were referred for HSG...
March 29, 2016: Abdom Radiol (NY)
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"